GE HealthCare to Acquire SOFIE Biosciences for U.S. PET Radiopharmaceutical Supply
GE HealthCare announced its acquisition of SOFIE Biosciences to establish a 'final mile' footprint for PET radiopharmaceutical supply in the United States. This move aims to enhance the distribution and availability of PET imaging agents, improving healthcare delivery and diagnostic capabilities across the country.
GE HealthCare·


